Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer.

MLA

Hamaya, Yasushi, et al. “Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer.” PloS One, vol. 10, no. 5, May 2015, p. e0127591. EBSCOhost, https://doi.org/10.1371/journal.pone.0127591.

APA

Hamaya, Y., Guarinos, C., Tseng-Rogenski, S. S., Iwaizumi, M., Das, R., Jover, R., Castells, A., Llor, X., Andreu, M., & Carethers, J. M. (2015). Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer. PloS One, 10(5), e0127591. https://doi.org/10.1371/journal.pone.0127591

Chicago

Hamaya, Yasushi, Carla Guarinos, Stephanie S Tseng-Rogenski, Moriya Iwaizumi, Ritabrata Das, Rodrigo Jover, Antoni Castells, Xavier Llor, Montserrat Andreu, and John M Carethers. 2015. “Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer.” PloS One 10 (5): e0127591. doi:10.1371/journal.pone.0127591.